Kategooriad: UudisedTeadusuuringud
Uudised
SOM Biotech lõpetab Huntingtoni tõve korea ravi IIb faasi uuringu värbamise protsessi
SOM Biotech, a clinical-stage drug discovery and development company based on a unique proprietary Artificial Intelligence platform (SOMAIPRO®), is pleased to announce that the recruitment of the Phase IIb clinical study with SOM3355 as a Loe edasi...
0 Märkused